The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...

Researchers from Australia and Bangladesh have developed an artificial intelligence model capable of spotting and distinguishing between multiple types of lung disease. Called LungNet, the tool ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body. Now, scientists at UC San Francisco have ...

Researchers at the Institute of Industrial Science, the University of Tokyo, have developed a system that allows human lung organoids to expand in a breathing-like manner by applying pressure from ...

Lung cancer remains one of the world's deadliest cancers, yet despite decades of effort to develop new drugs, many fail because they don't stay in the body long enough to be effective or because they ...

Biological assailants like fungi, bacteria, and viruses continuously test natural defenses that have evolved over millennia. Newer and stranger particles that originate from burning fuels, harmful ...

UCLA researchers have successfully grown miniature lungs from stem cells—complete with their own functioning blood vessel networks. Subscribe to our newsletter for the latest sci-tech news updates.

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

Researchers reveal critical mechanism behind idiopathic pulmonary fibrosis. Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...